Development of breast tumors in CHEK2, NBN/NBS1 and BLM mutation carriers does not commonly involve somatic inactivation of the wild-type allele.
about
Cytotoxic and targeted therapy for hereditary cancersThe DNA2 nuclease/helicase is an estrogen-dependent gene mutated in breast and ovarian cancersGenomic profiling of CHEK2*1100delC-mutated breast carcinomas.DNA repair genes implicated in triple negative familial non-BRCA1/2 breast cancer predisposition.Deleterious Germline BLM Mutations and the Risk for Early-onset Colorectal Cancer.Genomic profiling of pelvic genital type leiomyosarcoma in a woman with a germline CHEK2:c.1100delC mutation and a concomitant diagnosis of metastatic invasive ductal breast carcinoma.
P2860
Development of breast tumors in CHEK2, NBN/NBS1 and BLM mutation carriers does not commonly involve somatic inactivation of the wild-type allele.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Development of breast tumors i ...... ation of the wild-type allele.
@en
Development of breast tumors i ...... ation of the wild-type allele.
@nl
type
label
Development of breast tumors i ...... ation of the wild-type allele.
@en
Development of breast tumors i ...... ation of the wild-type allele.
@nl
prefLabel
Development of breast tumors i ...... ation of the wild-type allele.
@en
Development of breast tumors i ...... ation of the wild-type allele.
@nl
P2093
P2860
P50
P1433
P1476
Development of breast tumors i ...... vation of the wild-type allele
@en
P2093
Alexandr A Bessonov
Alexandr O Ivantsov
Evgeny N Imyanitov
Evgeny N Suspitsin
Olga A Zaitseva
Olga S Yatsuk
Valeria A Heinstein
Valery F Klimashevskiy
P2860
P2888
P356
10.1007/S12032-013-0828-9
P577
2014-01-12T00:00:00Z
P6179
1038443923